- The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016–2021.
- Roht L, Tooming M, Rekker K, Roomere H, Toome K, Murumets Ü, Šamarina U, Õunap K, Kahre T.
- Front Genet. 2022 Nov 8;12:1020543. doi: 10.3389/fgene.2022.1020543.
- Implementation of multigene panel testing for breast and ovarian cancer in South Africa: a step towards excellence in Oncology for the public sector.
- Van Der Merwe NC, Ntaita KS, Stofberg H, Combrink HM, Oosthuizen J, Kotze MJ.
- Front Oncol. 2022 Nov 8;12:938561. doi: 10.3389/fonc.2022.938561.
- Germline Pathogenic Variants Associated with Ovarian Cancer: A Historical Overview.
- Lund Johansen E, Fribert Thusgaard C, Thomassen M, Eriksen Boonen S, Jochumsen KM.
- Gynecol Oncol Rep. 2022 Nov 8;101105. doi: 10.1016/j.gore.2022.101105.
- Review
- Free Full Text
- Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
- Mori T, Okamoto Y, Mu A, Ide Y, Yoshimura A, Senda N, Inagaki-Kawata Y, Kawashima M, Kitao H, Tokunaga E, Miyoshi Y, Ohsumi S, Tsugawa K, Ohta T, Katagiri T, Ohtsuru S, Koike K, Ogawa S, Toi M, Iwata H, Nakamura S, Matsuo K, Takata M.
- Cancer Med. 2022 Nov 7. doi: 10.1002/cam4.5430. Epub ahead of print.
- PMID: 36345163
- PubMed abstract
- Source abstract
- A case of metastatic treatment-emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy.
- Naiki T, Naiki-Ito A, Kawai T, Komatsu H, Nishikawa R, Gonda M, Aoki M, Sugiyama Y, Tasaki Y, Yasui T.
- IJU Case Rep. 2022 Jun 29 [eCollection 2022 Nov];5(6):431-435. doi: 10.1002/iju5.12501.
- PMID: 36341200
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
- Free Full Text
•• Commentary:
Editorial Comment from Dr Sekino and Dr Hinata to A case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy.
- PMID: 36341205
- PubMed abstract
- Free Full Text
•• Commentary:
Editorial Comment from Dr Kato to A case of metastatic treatment-emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation by liver biopsy.
- PMID: 36341195
- PubMed abstract
- Free Full Text
- Prostate cancer recurring as small-cell carcinoma with a BRCA2 somatic mutation.
- Yabusaki R, Yoshimura K, Taku K, Suzuki M.
- IJU Case Rep. 2022 Aug 12 [eCollection 2022 Nov];5(6):489-492. doi: 10.1002/iju5.12523.
- PMID: 36341199
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
- Free Full Text